The Valley Desk

NCT01180790 · Interventional trial

Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants

Overall registry status Completed

Phase 2

Conditions Hepatitis C

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov